Literature DB >> 454285

Angiography and embolization of the internal maxillary artery for posterior epistaxis.

G H Roberson, E J Reardon.   

Abstract

Epistaxis that originates from the posterior aspect of the nasal cavity is most often due to hemorrhage from one of the branches of the internal maxillary artery. There are multiple methods of treatment of this problem that vary in effectiveness, complexity, and stress on the patient. Most cases are controlled with either packing or surgical arterial ligation, but occasionally patients either cannot tolerate this therapy or continue to hemorrhage. We describe ten patients who were referred to the Neuroradiology Section of the Massachusetts General Hospital from the Massachusetts Eye and Ear Infirmary for angiography and embolization of the internal maxillary artery for epistaxis.

Entities:  

Mesh:

Year:  1979        PMID: 454285     DOI: 10.1001/archotol.1979.00790180031006

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  5 in total

1.  Acute visual loss after preoperative embolization of an ethmoidal metastasis.

Authors:  Karsten Hufendiek; Katerina Hufendiek; Thomas Finkenzeller; Horst Helbig; Carsten Framme
Journal:  Int Ophthalmol       Date:  2012-02-16       Impact factor: 2.031

2.  Embolization of tumors and vascular lesions in the oral and maxillofacial regions.

Authors:  W Chen; J Qi
Journal:  J Tongji Med Univ       Date:  1998

3.  Transcatheter embolization in the management of intractable uremic epistaxis.

Authors:  R F Gagnon; B Ballermann; P Bourgouin; M J Herba; M Kaye
Journal:  Can Med Assoc J       Date:  1982-01-15       Impact factor: 8.262

4.  Ischemic necrosis of nose and palate after embolization for epistaxis. A case report.

Authors:  Aris Ntomouchtsis; Gregory Venetis; Lambros Zouloumis; Nicolas Lazaridis
Journal:  Oral Maxillofac Surg       Date:  2010-06

Review 5.  Assessment of safety and efficacy of arterial embolisation in the management of intractable epistaxis.

Authors:  Maziar Sadri; Katie Midwinter; Aftab Ahmed; Andrew Parker
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-21       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.